Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
(2S,5S,8S,11S,14S,17S,20S,23S,26S,29S,32S,35S,38S,41S,44S,47S,50S)-35-((1H-indol-3-yl)methyl)-50,54-diamino-8,11,17,20,29,32,41-heptakis(4-aminobutyl)-38-benzyl-5-sec-butyl-44,47-bis(3-guanidinopropyl)-2,14,23-triisobutyl-26-isopropyl-4,7,10,13,16,19,22,25,28,31,34,37,40,43,46,49-hexadecaoxo-3,6,9,12,15,18,21,24,27,30,33,36,39,42,45,48-hexadecaazatetrapentacontan-1-oic acid
ID: ALA5270677
Chembl Id: CHEMBL5270677
Max Phase: Preclinical
Molecular Formula: C109H194N32O18
Molecular Weight: 2240.96
Associated Items: